{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:00:36Z","timestamp":1784883636471,"version":"3.55.0"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Patients with schizophrenia spectrum disorders are a clinically complex group in need of focused, multidisciplinary care in the perinatal period. During pregnancy, these patients are at increased risk of substance use disorders and child protective services involvement, as well as multiple adverse obstetric and neonatal outcomes. Coordinated care with psychiatry is critical, as psychotropic medication treatment can improve maternal and neonatal outcomes. Even with medication treatment, the variability in impairments to patient autonomy requires attention to decision-making for these individuals. This review highlights best practices when caring for patients with schizophrenia spectrum disorders from preconception through postpartum.<\/jats:p>","DOI":"10.1097\/grf.0000000000001027","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:01:38Z","timestamp":1781179298000},"page":"344-354","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Obstetric Care of the Patient With Schizophrenia Spectrum Disorders"],"prefix":"10.1097","volume":"69","author":[{"given":"Kara","family":"Stoever","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maithri","family":"Ameresekere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"R3-20260724","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(14)61278-2","article-title":"Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the postpartum period","volume":"384","author":"Jones","year":"2014","journal-title":"Lancet"},{"key":"R4-20260724","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/pcn.12856","article-title":"Schizophrenia and motherhood","volume":"73","author":"Gentile","year":"2019","journal-title":"Psychiatry Clin Neurosci"},{"key":"R5-20260724","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12884-018-1750-0","article-title":"Adverse obstetric and neonatal outcomes complicated by psychosis among pregnant women in the United States","volume":"18","author":"Zhong","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"R6-20260724","first-page":"5","article-title":"Sexual and intimate partner violence against women with schizophrenia: a scoping review","volume":"23","author":"B\u00e9lisle","year":"2024","journal-title":"Grad Stud J Psychol"},{"key":"R7-20260724","doi-asserted-by":"crossref","first-page":"E322","DOI":"10.1503\/cmaj.220689","article-title":"Risk of interpersonal violence during and after pregnancy among people with schizophrenia: a population-based cohort study","volume":"195","author":"Leslie","year":"2023","journal-title":"CMAJ"},{"key":"R8-20260724","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1377\/hlthaff.2023.01450","article-title":"Addressing pregnancy and parenting in mental health care: perspectives of women with serious mental illness","volume":"43","author":"Fenwick","year":"2024","journal-title":"Health Aff (Millwood)"},{"key":"R10-20260724","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s40263-025-01218-z","article-title":"Antipsychotic-related prolactin changes: a systematic review and dose-response meta-analysis","volume":"39","author":"Lin","year":"2025","journal-title":"CNS Drugs"},{"key":"R11-20260724","doi-asserted-by":"crossref","first-page":"100413","DOI":"10.1016\/j.ajogmf.2021.100413","article-title":"Associations between inpatient psychiatric admissions during pregnancy and adverse obstetrical and birth outcomes","volume":"3","author":"Whelan","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R12-20260724","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YCO.0000000000000706","article-title":"Schizophrenia during pregnancy","volume":"34","author":"Dazzan","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"R13-20260724","first-page":"1","article-title":"Intervention to prevent child custody loss in mothers with schizophrenia","volume":"2012","author":"Seeman","year":"2011","journal-title":"Schizophr Res Treat"},{"key":"R14-20260724","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.schres.2023.11.001","article-title":"Adverse perinatal pregnancy outcomes in women with schizophrenia: a systematic review and meta-analysis","volume":"262","author":"Tang","year":"2023","journal-title":"Schizophr Res"},{"key":"R15-20260724","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00127-019-01814-7","article-title":"Maternal schizophrenia and adverse birth outcomes: what mediates the risk?","volume":"55","author":"Vigod","year":"2020","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"R16-20260724","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1016\/j.ajog.2008.09.001","article-title":"The clinical content of preconception care: women with psychiatric conditions","volume":"199","author":"Frieder","year":"2008","journal-title":"AJOG"},{"key":"R17-20260724","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/AOG.0000000000005202","article-title":"Committee on Clinical Practice Guidelines-Obstetrics. Treatment and management of mental health conditions during pregnancy and postpartum: ACOG Clinical Practice Guideline No. 5","volume":"141","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R20-20260724","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0447.2012.01897.x","article-title":"Clinical interventions for women with schizophrenia: pregnancy","volume":"127","author":"Seeman","year":"2013","journal-title":"Acta Psychiatr Scand"},{"key":"R21-20260724","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ajmg.a.33193","article-title":"Genetic counseling for schizophrenia: a review of referrals to a provincial medical genetics program from 1968\u20132007","volume":"152A","author":"Hunter","year":"2010","journal-title":"Am J Med Genet A"},{"key":"R22-20260724","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpsychires.2018.06.019","article-title":"Predictors of severe relapse in pregnant women with psychotic or bipolar disorders","volume":"104","author":"Taylor","year":"2018","journal-title":"J Psychiatric Res"},{"key":"R23-20260724","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1192\/bjp.2024.247","article-title":"Antipsychotic continuation during pregnancy and risk of postpartum relapse in women with schizophrenia: nationwide register-based study","volume":"227","author":"Kang","year":"2025","journal-title":"Br J Psychiatry"},{"key":"R24-20260724","doi-asserted-by":"crossref","first-page":"255","DOI":"10.9740\/mhc.2023.12.255","article-title":"Concepts for selection and utilization of psychiatric medications in pregnancy","volume":"13","author":"Vickery","year":"2023","journal-title":"Mental Health Clinician"},{"key":"R25-20260724","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/GRF.0000000000000377","article-title":"Psychiatric emergencies in pregnancy and postpartum","volume":"61","author":"Rodriguez-Cabezas","year":"2018","journal-title":"Clin Obstet Gynecol"},{"issue":"suppl 2","key":"R26-20260724","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_12_22","article-title":"Management of psychiatric disorders during the perinatal period","volume":"64","author":"Bharadwaj","year":"2022","journal-title":"Indian J Psychiatry"},{"key":"R27-20260724","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881119889296","article-title":"Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology","volume":"34","author":"Barnes","year":"2019","journal-title":"J Psychopharmacol"},{"key":"R28-20260724","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/07067437241303031","article-title":"Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l\u2019humeur, des troubles anxieux et des troubles connexes p\u00e9rinatals","volume":"70","author":"Vigod","year":"2025","journal-title":"Can J Psychiatry"},{"key":"R29-20260724","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40211-025-00550-6","article-title":"Optimal care for mother and baby in severe postpartum mental illness","volume":"40","author":"Sanadi","year":"2026","journal-title":"Neuropsychiatrie"},{"key":"R30-20260724","doi-asserted-by":"crossref","first-page":"20451253241263715","DOI":"10.1177\/20451253241263715","article-title":"Long-acting antipsychotic treatments: focus on women with schizophrenia","volume":"14","author":"Brissos","year":"2024","journal-title":"Ther Adv Psychopharmacol"},{"key":"R31-20260724","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1017\/S0033291721004591","article-title":"Antipsychotic medication for women with schizophrenia spectrum disorders","volume":"52","author":"Brand","year":"2021","journal-title":"Psychol Med"},{"key":"R32-20260724","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00787-018-1177-1","article-title":"Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis","volume":"27","author":"Poels","year":"2018","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R33-20260724","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamainternmed.2021.4571","article-title":"Association between prenatal exposure to antipsychotics and attention-deficit\/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age","volume":"181","author":"Wang","year":"2021","journal-title":"JAMA Intern Med"},{"key":"R34-20260724","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/ebmental-2021-300311","article-title":"Original research: antipsychotic use in pregnancy and risk of attention\/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study","volume":"25","author":"H\u00e1lfd\u00e1narson","year":"2022","journal-title":"Evid Based Ment Health"},{"key":"R35-20260724","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamainternmed.2022.0375","article-title":"Association of antipsychotic drug exposure in pregnancy with risk of neurodevelopmental disorders: a national birth cohort study","volume":"182","author":"Straub","year":"2022","journal-title":"JAMA Intern Med"},{"key":"R36-20260724","doi-asserted-by":"crossref","first-page":"152419","DOI":"10.1016\/j.comppsych.2023.152419","article-title":"Cardiometabolic screening and monitoring in patients prescribed antipsychotic drugs in primary care: a population-based cohort study","volume":"127","author":"Azfr Ali","year":"2023","journal-title":"Compr Psychiatry"},{"key":"R37-20260724","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1111\/bcp.14839","article-title":"Prenatal exposure to antipsychotic agents and the risk of congenital malformations in children: a systematic review and meta-analysis","volume":"87","author":"Wang","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"R38-20260724","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40263-022-00908-2","article-title":"Antipsychotic use during pregnancy and risk for gestational diabetes: a national register-based cohort study in Sweden","volume":"36","author":"Heinonen","year":"2022","journal-title":"CNS Drugs"},{"key":"R39-20260724","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/AOG.0000000000000759","article-title":"Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy","volume":"125","author":"Coughlin","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R40-20260724","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","article-title":"Antipsychotic use in pregnancy and the risk for congenital malformations","volume":"73","author":"Huybrechts","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"R41-20260724","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.euroneuro.2016.08.008","article-title":"Mood stabilizers and antipsychotics during breastfeeding: focus on bipolar disorder","volume":"26","author":"Pacchiarotti","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"R42-20260724","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JCP.0000000000000491","article-title":"Second-generation antipsychotics during the lactation period: a comparative systematic review on infant safety","volume":"36","author":"Uguz","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"R43-20260724","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaclp.2021.08.011","article-title":"Long-acting injectable antipsychotic medications in pregnancy: a review","volume":"63","author":"O\u2019Sullivan","year":"2022","journal-title":"Journal of the Academy of Consultation-Liaison Psychiatry"},{"key":"R44-20260724","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.20ac13597","article-title":"Long-acting injectable antipsychotic use during pregnancy","volume":"81","author":"Reinstein","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"R45-20260724","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13023-019-1064-y","article-title":"Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability","volume":"14","author":"Clayton-Smith","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"R46-20260724","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","article-title":"Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes","volume":"15","author":"Veroniki","year":"2017","journal-title":"BMC Med"},{"key":"R47-20260724","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"R48-20260724","doi-asserted-by":"crossref","first-page":"e0131130","DOI":"10.1371\/journal.pone.0131130","article-title":"Congenital anomalies in children of mothers taking antiepileptic drugs with and without periconceptional high dose folic acid use: a population-based cohort study","volume":"10","author":"Ban","year":"2015","journal-title":"PLoS One"},{"key":"R49-20260724","doi-asserted-by":"crossref","first-page":"17362","DOI":"10.1038\/s41598-020-74409-x","article-title":"Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France","volume":"10","author":"Coste","year":"2020","journal-title":"Sci Rep"},{"key":"R50-20260724","doi-asserted-by":"crossref","first-page":"151221","DOI":"10.1016\/j.semperi.2020.151221","article-title":"Drugs in pregnancy: Pharmacologic and physiologic changes that affect clinical care","volume":"44","author":"Pinheiro","year":"2020","journal-title":"Semin Perinatol"},{"issue":"pt A","key":"R51-20260724","doi-asserted-by":"crossref","first-page":"120633","DOI":"10.1016\/j.jad.2025.120633","article-title":"Antipsychotic use during pregnancy and risk of gestational diabetes: an updated meta-analysis","volume":"395","author":"Zhang","year":"2026","journal-title":"J Affect Disord"},{"key":"R52-20260724","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/acps.13623","article-title":"Safety of and response to electroconvulsive therapy during pregnancy: results from population-based nationwide registries","volume":"150","author":"Arnison","year":"2024","journal-title":"Acta Psychiatr Scand"},{"key":"R53-20260724","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00737-023-01394-1","article-title":"Safety of electroconvulsive therapy (ECT) in pregnancy: a systematic review of case reports and case series","volume":"27","author":"Cipolla","year":"2024","journal-title":"Arch Womens Ment Health"},{"key":"R54-20260724","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1067\/mob.2002.125767","article-title":"Ethical challenges of decision making with pregnant patients who have schizophrenia","volume":"187","author":"McCullough","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R55-20260724","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMcp074045","article-title":"Assessment of patients\u2019 competence to consent to treatment","volume":"357","author":"Appelbaum","year":"2007","journal-title":"N Engl J Med"},{"key":"R56-20260724","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/01.AOG.0000291573.09193.36","article-title":"Ethical decision making in obstetrics and gynecology: ACOG Committee Opinion No. 390","volume":"110","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R57-20260724","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1378\/chest.11-2336","article-title":"Legal fundamentals of surrogate decision making","volume":"141","author":"Pope","journal-title":"Chest"},{"key":"R60-20260724","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2019.2587","article-title":"US state regulation of decisions for pregnant women without decisional capacity","volume":"321","author":"DeMartino","year":"2019","journal-title":"JAMA"},{"key":"R61-20260724","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.genhosppsych.2004.07.002","article-title":"When agreeing with the patient is not enough: a schizophrenic woman requests pregnancy termination","volume":"26","author":"Dudzinski","year":"2004","journal-title":"Gen Hosp Psychiatry"},{"key":"R62-20260724","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00404-019-05258-x","article-title":"Obstetric outcomes for women with severe mental illness: 10 years of experience in a tertiary multidisciplinary antenatal clinic","volume":"300","author":"Frayne","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"R63-20260724","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/AOG.0000000000005200","article-title":"Screening and diagnosis of mental health conditions during pregnancy and postpartum: ACOG Clinical Practice Guideline No. 4","volume":"141","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R64-20260724","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1192\/bjp.bp.116.192799","article-title":"Lithium dosing strategies during pregnancy and the postpartum period","volume":"211","author":"Wesseloo","year":"2017","journal-title":"Br J Psychiatry"},{"key":"R65-20260724","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.psc.2017.05.017","article-title":"Behavioral emergencies: special considerations in the pregnant patient","volume":"40","author":"Aftab","year":"2017","journal-title":"Psychiatr Clin North Am"},{"key":"R66-20260724","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/schbul\/sbab085","article-title":"Maternal schizophrenia, skin-to-skin contact, and infant feeding initiation","volume":"48","author":"Taylor","year":"2022","journal-title":"Schizophr Bull"},{"key":"R67-20260724","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.psym.2015.09.004","article-title":"The Cornell Peripartum Psychosis Management Tool: a case series and template","volume":"57","author":"Chaudhry","year":"2016","journal-title":"Psychosomatics"},{"issue":"3","key":"R68-20260724","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/journalofethics.2016.18.3.ecas2-1603","article-title":"Managing care of an intrapartum patient with agitation and psychosis: ethical and legal implications","volume":"18","author":"McCullough","year":"2016","journal-title":"AMA J Ethics"},{"key":"R69-20260724","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.biopsych.2025.10.016","article-title":"Postpartum psychosis and bipolar disorder: review of neurobiology and expert consensus statement on classification","volume":"99","author":"Bergink","year":"2025","journal-title":"Biol Psychiatry"},{"key":"R70-20260724","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ogc.2018.04.005","article-title":"Recognizing and managing postpartum psychosis: a clinical guide for obstetric providers","volume":"45","author":"Osborne","year":"2018","journal-title":"Obstet Gynecol Clin N Am"},{"key":"R71-20260724","doi-asserted-by":"crossref","first-page":"100359","DOI":"10.1016\/j.bbih.2021.100359","article-title":"The role of the immune system in postpartum psychosis","volume":"18","author":"Hazelgrove","year":"2021","journal-title":"Brain Behav Immun Health"},{"key":"R72-20260724","doi-asserted-by":"crossref","first-page":"18022","DOI":"10.1038\/nrdp.2018.22","article-title":"Postpartum psychiatric disorders","volume":"4","author":"Meltzer-Brody","year":"2018","journal-title":"Nat Rev Dis Primer"},{"key":"R73-20260724","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/jcm12020656","article-title":"A review: integrative perspectives on the features and clinical management of psychotic episodes in pregnancy","volume":"12","author":"Ortega","year":"2023","journal-title":"J Clin Med"},{"key":"R75-20260724","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12888-019-2389-8","article-title":"A qualitative comparison of experiences of specialist mother and baby units versus general psychiatric wards","volume":"19","author":"Griffiths","year":"2019","journal-title":"BMC Psychiatry"},{"key":"R76-20260724","doi-asserted-by":"crossref","first-page":"e2022057988","DOI":"10.1542\/peds.2022-057988","article-title":"Section on breastfeeding; policy statement: breastfeeding and the use of human milk","volume":"150","author":"Meek","year":"2022","journal-title":"Pediatrics"},{"key":"R78-20260724","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.12788\/cp.0428","article-title":"Breastfeeding by patients with serious mental illness: an ethical approach","volume":"22","author":"Soundararajan","year":"2023","journal-title":"Curr Psychiatry"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000001027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:01:35Z","timestamp":1784880095000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000001027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000001027","relation":{},"ISSN":["0009-9201","1532-5520"],"issn-type":[{"value":"0009-9201","type":"print"},{"value":"1532-5520","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]}}}